Results 141 to 150 of about 14,254 (195)

[Research Progress and New Immunotherapy Strategies of Tumor Microenvironment Metabolism]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban, 2023
Peng YM, Luo XM, Chen JY.
europepmc   +1 more source

[Current status and progress of health economics research on allergen specific immunotherapy]. [PDF]

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
Hu Q, Li L, Long Z, Huo B, Hao Y, Cheng X, Xie T, Cheng Q, Zhou T, Zhou L, Chen S, Zhou Y, Chen J.   +12 more
europepmc   +1 more source

[Advances in Immunotherapy for Malignant Pleural Mesothelioma]. [PDF]

Zhongguo Fei Ai Za Zhi, 2022
Chi Y, Liu Y, Zhao J.
europepmc   +1 more source

Predictive value of NUF2 for prognosis and immunotherapy responses in pan-cancer. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Wang Y, Chen L, Luo Y, Shen J, Zhou S.
europepmc   +1 more source

[Demographic features and compliance of children with allergic diseases receiving sublingual immunotherapy]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi, 2022
Huang RR, Zhu XH, Wang JL.
europepmc   +1 more source

Biomarkers in oral immunotherapy. [PDF]

J Zhejiang Univ Sci B, 2022
Zhu H, Tang K, Chen G, Liu Z.
europepmc   +1 more source

强化免疫抑制治疗儿童再生障碍性贫血疗效分析

Zhongshan Daxue xuebao. Yixue kexue ban, 2004
【目的】探讨强化免疫抑制治疗儿童再生障碍性贫血的疗效及毒副作用的防治。【方法】总结我科1996—2003年儿童再障32例,均采用强化免疫抑制治疗(IIST),根据免疫抑制药物的不同组合分为2组:4种药物联合组和2～3种药物联合组。【结果】总有效率为71.88%,4种药物联合组、2～3种药物联合组有效率分别为72.2%及71.33%,差别无显著性。治疗过程中,致命的合并症为败血症,尤其潜伏病毒激活及深部真菌感染。随访中没有病例发展为阵发性睡眠性血红蛋白尿(PNH),骨髓异常增生综合征(MDS ...
doaj  

[Tumor microenvironment-specific CT radiomics signature for predicting immunotherapy response in non-small cell lung cancer]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Huang Q, Xie D, Yao L, Li Q, Wu S, Zhou H.   +5 more
europepmc   +1 more source

Recent research on immunotherapy for anti-N-methyl-D-aspartate receptor encephalitis. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi, 2022
Li YH, Jiang L.
europepmc   +1 more source

自体细胞因子诱导的杀伤细胞过继性免疫治疗恶性肿瘤的临床观察

临床医学前沿
姜 洋
semanticscholar   +1 more source